{"id":"https://openalex.org/W2590633587","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2525","title":"Phase I study of abiraterone acetate (AA) in patients (pts) with estrogen receptor\u2013 (ER) or androgen receptor (AR) \u2013positive advanced breast carcinoma resistant to standard endocrine therapies.","display_name":"Phase I study of abiraterone acetate (AA) in patients (pts) with estrogen receptor\u2013 (ER) or androgen receptor (AR) \u2013positive advanced breast carcinoma resistant to standard endocrine therapies.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2590633587","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2525","mag":"2590633587"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.2525","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2525","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.2525","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017721654","display_name":"Bristi Basu","orcid":"https://orcid.org/0000-0002-3562-2868","observed_orcids":["https://orcid.org/0000-0002-3562-2868"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Basu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032749624","display_name":"Joo Ern Ang","orcid":"https://orcid.org/0000-0003-2103-996X","observed_orcids":["https://orcid.org/0000-0003-2103-996X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. E. Ang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002551277","display_name":"Danielle Crawley","orcid":"https://orcid.org/0000-0001-7294-5634","observed_orcids":["https://orcid.org/0000-0001-7294-5634"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Crawley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062620682","display_name":"Elizabeth J. Folkerd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Folkerd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089670001","display_name":"Debashis Sarker","orcid":"https://orcid.org/0000-0003-4814-8429","observed_orcids":["https://orcid.org/0000-0003-4814-8429","https://orcid.org/0000-0001-6948-2974"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Sarker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047350091","display_name":"Montserrat Blanco-Codesido","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Blanco-Codesido","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"K. Moran","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Moran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013494824","display_name":"Susan Wan","orcid":"https://orcid.org/0000-0001-7662-2269","observed_orcids":["https://orcid.org/0000-0001-7662-2269"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Wan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076812888","display_name":"Nicola A. Dobbs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Dobbs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058014829","display_name":"Florence I. Raynaud","orcid":"https://orcid.org/0000-0003-0957-6279","observed_orcids":["https://orcid.org/0000-0003-0957-6279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Raynaud","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031915637","display_name":"Stephen R.D. Johnston","orcid":"https://orcid.org/0000-0002-9072-2749","observed_orcids":["https://orcid.org/0000-0002-9072-2749"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. R. D. Johnston","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057689412","display_name":"Mitch Dowsett","orcid":"https://orcid.org/0000-0003-4122-744X","observed_orcids":["https://orcid.org/0000-0003-4122-744X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Dowsett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087121536","display_name":"Andrew N.J. Tutt","orcid":"https://orcid.org/0000-0001-8715-2901","observed_orcids":["https://orcid.org/0000-0001-8715-2901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. N. J. Tutt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034748028","display_name":"James F. Spicer","orcid":"https://orcid.org/0000-0003-3732-8491","observed_orcids":["https://orcid.org/0000-0003-3732-8491","https://orcid.org/0009-0005-6890-2128"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. F. Spicer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016475369","display_name":"Charles Swanton","orcid":"https://orcid.org/0000-0002-4299-3018","observed_orcids":["https://orcid.org/0000-0002-4299-3018"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Swanton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. S. De Bono","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"2525","last_page":"2525"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.6255000233650208,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.6255000233650208,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.1468999981880188,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.11330000311136246,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.9200000166893005},{"id":"https://openalex.org/keywords/androgen-receptor-positive-breast-cancer","display_name":"androgen receptor-positive breast cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cyp17-inhibitors","display_name":"CYP17 inhibitors","score":0.9129999876022339},{"id":"https://openalex.org/keywords/androgen-synthesis-inhibition","display_name":"androgen synthesis inhibition","score":0.7429999709129333},{"id":"https://openalex.org/keywords/hypokalemia","display_name":"hypokalemia","score":0.871999979019165},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6039999723434448},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.5509999990463257},{"id":"https://openalex.org/keywords/antitumour-activity","display_name":"antitumour activity","score":0.6769999861717224},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.7059999704360962},{"id":"https://openalex.org/keywords/ca-15-3","display_name":"CA15-3","score":0.7829999923706055}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8360331058502197},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.683079719543457},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6158870458602905},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.579331636428833},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.49399739503860474},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4533819258213043},{"id":"https://openalex.org/C2778242168","wikidata":"https://www.wikidata.org/wiki/Q794086","display_name":"Hypokalemia","level":2,"score":0.44389820098876953},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.4026283621788025},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.33525627851486206},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30947721004486084}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.2525","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2525","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.2525","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2999099920","https://openalex.org/W2766299904","https://openalex.org/W2597533030","https://openalex.org/W1624779450","https://openalex.org/W2341536338","https://openalex.org/W2999663476","https://openalex.org/W2337248088","https://openalex.org/W2806719596","https://openalex.org/W2599269456","https://openalex.org/W2261036306"],"abstract_inverted_index":{"2525":[0],"Background:":[1],"Many":[2],"advanced":[3,80,282],"ER+":[4,69,77],"breast":[5,41,81,283],"cancer":[6,82,284],"pts":[7,109,119,246,285],"show":[8],"intrinsic":[9],"resistance":[10],"to":[11,30,45,84,167,235],"endocrine":[12],"treatment":[13,126],"with":[14,76,95,117,182,196,217,286],"the":[15,113,222,237,243],"remainder":[16],"acquiring":[17],"resistance.":[18],"Androgenic":[19],"steroids":[20],"upstream":[21],"of":[22,40,87,107,143,229,240,242,256,289,306],"aromatase":[23],"can":[24,299],"drive":[25],"steroid":[26],"receptor":[27],"signaling":[28],"critical":[29],"tumour":[31],"growth.":[32],"Evidence":[33],"also":[34],"exists":[35],"for":[36],"an":[37],"ER\u03b1-/AR+":[38],"subset":[39],"cancers":[42],"transcriptionally":[43],"similar":[44],"ER\u03b1+":[46],"disease.":[47],"We":[48],"hypothesized":[49],"that":[50,57],"AA,":[51],"a":[52,259],"cytochrome":[53],"(CYP)":[54],"17":[55],"inhibitor":[56],"irreversibly":[58],"inhibits":[59],"androgen":[60],"and":[61,101,161,192,206,214,233,263,298],"estrogen":[62],"synthesis,":[63],"would":[64],"have":[65],"anti-tumour":[66],"activity":[67],"in":[68,92,112,175,266,281],"or":[70,78,153],"ER-/AR+":[71,79],"pts.":[72,177],"Methods:":[73],"Post-menopausal":[74],"women":[75],"resistant":[83],">2":[85],"lines":[86],"hormone":[88],"therapies":[89],"were":[90,110,136,147,204],"treated":[91,111],"6-pt":[93],"cohorts":[94],"AA":[96,277],"at":[97],"doses":[98],"between":[99],"250":[100],"2000mg":[102,223],"daily.":[103],"Results:":[104],"A":[105],"total":[106],"25":[108],"phase":[114],"I":[115],"trial":[116],"2":[118],"ongoing":[120],"on":[121,125,250],"study.":[122],"Median":[123],"time":[124],"was":[127,164,179],"1.8":[128],"mths":[129],"(range":[130],"0.7":[131],"\u2013":[132],"11.6":[133],"mths).":[134],"There":[135],"no":[137,197],"dose":[138,224],"limiting":[139],"toxicities.":[140],"The":[141,292],"majority":[142],"adverse":[144],"events":[145],"(AEs)":[146],"Common":[148],"Toxicity":[149],"Criteria":[150],"grade":[151,171,201],"1":[152],"2:":[154],"fatigue,":[155],"nausea,":[156],"anorexia,":[157],"dyspnoea,":[158],"palpitations,":[159],"dizziness":[160,218],"flushes.":[162],"Hypokalemia":[163],"frequent,":[165],"due":[166],"secondary":[168],"mineralocorticoid":[169],"syndrome:":[170],"3/4":[172],"hypokalemia":[173],"occurred":[174],"4":[176],"This":[178],"effectively":[180],"managed":[181,301],"potassium":[183,307],"supplementation,":[184],"hydrocortisone":[185],"(20":[186],"mg":[187,190],"mane,":[188],"10":[189],"nocte)":[191],"eplerenone":[193],"(50-200":[194],"mg)":[195],"clinical":[198],"consequences.":[199],"Other":[200],"3":[202],"AEs":[203,294],"neutropenia":[205],"reduced":[207],"left":[208],"ventricular":[209],"ejection":[210],"fraction":[211],"(1":[212,219],"pt)":[213],"exercise-induced":[215],"hypotension":[216],"pt).":[220],"At":[221],"5/5":[225],"subjects":[226],"had":[227],"suppression":[228],"estradiol,":[230],"testosterone,":[231],"DHEA":[232],"DHEAS":[234],"below":[236],"lower":[238],"limit":[239],"detection":[241],"assay.":[244],"Two":[245],"(both":[247],"ER+/AR+)":[248],"continued":[249],"study":[251],"beyond":[252],"11":[253],"mths,":[254],"one":[255],"whom":[257],"achieved":[258],"radiological":[260],"partial":[261],"response":[262],"80%":[264],"reduction":[265],"serum":[267],"CA15.3":[268],"from":[269],"baseline.":[270],"Pharmacokinetic":[271],"data":[272],"will":[273],"be":[274,300],"presented.":[275],"Conclusions:":[276],"is":[278,309],"well":[279],"tolerated":[280],"preliminary":[287],"evidence":[288],"antitumour":[290],"activity.":[291],"predominant":[293],"are":[295],"mechanism-based":[296],"(hypokalemia)":[297],"expectantly,":[302],"although":[303],"careful":[304],"monitoring":[305],"levels":[308],"recommended.":[310]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2017-03-03T00:00:00"}